Utah Medical Products Inc
NASDAQ:UTMD
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Utah Medical Products Inc
NASDAQ:UTMD
|
216.8m USD |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
62.5B USD |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
31.8B CHF |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
108.5B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.7B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.3B USD |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
40.9B CNY |
Loading...
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.1B CHF |
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
790.8B JPY |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Utah Medical Products Inc
Glance View
Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. The company is headquartered in Midvale, Utah and currently employs 178 full-time employees. UTMD’s products include Blood Monitoring, which includes Deltran Disposable Blood Pressure Transducers, Deltran Plus Arterial Blood Sampling Systems, and Deltran Accessories; Electrosurgery, which includes Epitome Electrosurgical Scalpels, OptiMicro Ultra-Fine Tip Electrosurgical Needles, Finesse+ Electrosurgical Generators, Filtresse Surgical Smoke Evacuation Systems and Finesse+ Accessories; Labor and Delivery, which includes AROM-Cot, BT-Cath, CVX-Ripe, Intran, Muc-X and Cordguard; Neonatal Intensive Care, which includes Hemo-Nate, Thora-Cath, Nutri-Cath, Nutri-Lok, Myelo-Nate, Disposa-Hood, Neonatal Deltran, Pala-Nate, PICC-Nate, Dialy-Nate, Umbili-Cath and Uri-Cath; Urological Care, which includes the Liberty, Supra-Foley, and Pathfinder Plus; Womens Pelvic Health, and original equipment manufacturer/Capabilities.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Utah Medical Products Inc is 57.1%, which is below its 3-year median of 59.4%.
Over the last 3 years, Utah Medical Products Inc’s Gross Margin has decreased from 62% to 57.1%. During this period, it reached a low of 57.1% on Sep 30, 2025 and a high of 62% on Sep 30, 2022.
